1. First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. Issue 6 (12th February 2020) Authors: Chughlay, M. Farouk; Rossignol, Emilie; Donini, Cristina; El Gaaloul, Myriam; Lorch, Ulrike; Coates, Simon; Langdon, Grant; Hammond, Tim; Möhrle, Jörg; Chalon, Stephan Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 6(2020) Page Start: 1113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine. Issue 4 (14th September 2021) Authors: Chalon, Stephan; Chughlay, M. Farouk; Abla, Nada; Marie Tchouatieu, Andre; Haouala, Amina; Hutter, Ben; Lorch, Ulrike; Macintyre, Fiona Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 4(2022) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗